Progress in clinical research of transjugular intrahepatic portosystemic shunt for the treatment of portal cavernous transformation
10.3969/j.issn.1008-794X.2025.08.018
- VernacularTitle:经颈静脉肝内门体分流术治疗门静脉海绵样变的临床进展
- Author:
Jiayang ZHU
1
;
Bing ZHOU
;
Xuanyi CHEN
;
Junkang WANG
;
Bo LI
;
Rongqing QIN
;
Yubo ZHANG
;
Ruochen HU
Author Information
1. 310015 浙江杭州 杭州师范大学附属医院介入血管科
- Keywords:
cavernous transformation of portal vein;
transjugular intrahepatic portosystemic shunt;
portal hypertension;
diagnosis;
treatment
- From:
Journal of Interventional Radiology
2025;34(8):900-904
- CountryChina
- Language:Chinese
-
Abstract:
Clinically,the incidence of portal vein thrombosis(PVT)in patients with cirrhosis can be up to 10％-23％.When PVT is not treated promptly,it may develop to cavernous transformation of the portal vein(CTPV).CTPV can aggravate portal hypertension,accelerate the progression of esophagogastric varices bleeding,refractory ascites,refractory peritonitis,biliary tract diseases,and hepatic insufficiency.At present,noninvasive imaging techniques such as portal vein reconstruction,enhanced CT and ultrasound are mostly used to make the diagnosis and evaluation of CTPV.It is rather difficult to perform portosystemic shunt surgery in patients with CTPV complicated by portal hypertension,which was once regarded as a contraindication for interventional portosystemic shunt procedures.With the improvement of related technologies and surgical instruments,the transjugular intrahepatic portosystemic shunt(TIPS)has become an important treatment for CTPV.This paper aims to make a comprehensive review about the relevant researches concerning the portosystemic shunt surgery in patients with CTPV so as to clarify the importance of TIPS in the treatment of CTPV.
